Exencial Wealth Advisors, LLC Novo Nordisk A S Transaction History

Exencial Wealth Advisors, LLC

  • $2.72 Billion
  • Q3 2024

A detailed history of Exencial Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 22,970 shares of NVO stock, worth $2.01 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
22,970
Previous 22,376 2.65%
Holding current value
$2.01 Million
Previous $3.19 Million 14.34%
% of portfolio
0.1%
Previous 0.12%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$119.07 - $145.42 $70,727 - $86,379
594 Added 2.65%
22,970 $2.74 Million
Q2 2024

Aug 12, 2024
SELL
$122.71 - $146.91 $28,836 - $34,523
-235 Reduced 1.04%
22,376 $3.19 Million
Q1 2024

May 10, 2024
BUY
$102.11 - $135.92 $143,770 - $191,375
1,408 Added 6.64%
22,611 $2.9 Million
Q4 2023

Feb 13, 2024
SELL
$87.78 - $105.45 $129,826 - $155,960
-1,479 Reduced 6.52%
21,203 $2.19 Million
Q3 2023

Nov 08, 2023
BUY
$90.94 - $199.54 $933,862 - $2.05 Million
10,269 Added 82.73%
22,682 $2.06 Million
Q2 2023

Aug 10, 2023
BUY
$155.98 - $172.65 $83,605 - $92,540
536 Added 4.51%
12,413 $2.01 Million
Q1 2023

May 02, 2023
SELL
$132.34 - $159.14 $9.54 Million - $11.5 Million
-72,108 Reduced 85.86%
11,877 $1.89 Million
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $1.39 Million - $1.83 Million
-13,533 Reduced 13.88%
83,985 $11.4 Million
Q3 2022

Nov 08, 2022
BUY
$95.28 - $116.93 $287,650 - $353,011
3,019 Added 3.19%
97,518 $9.72 Million
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $3.52 Million - $4.15 Million
-34,074 Reduced 26.5%
94,499 $10.5 Million
Q1 2022

May 12, 2022
BUY
$93.1 - $112.54 $658,403 - $795,882
7,072 Added 5.82%
128,573 $14.3 Million
Q4 2021

Feb 10, 2022
BUY
$95.88 - $117.08 $675,954 - $825,414
7,050 Added 6.16%
121,501 $13.6 Million
Q3 2021

Nov 04, 2021
BUY
$84.42 - $106.62 $235,700 - $297,683
2,792 Added 2.5%
114,451 $11 Million
Q2 2021

Aug 16, 2021
BUY
$67.66 - $84.76 $225,037 - $281,911
3,326 Added 3.07%
111,659 $9.35 Million
Q1 2021

May 06, 2021
BUY
$67.06 - $75.82 $715,194 - $808,620
10,665 Added 10.92%
108,333 $7.3 Million
Q4 2020

Feb 11, 2021
SELL
$63.89 - $73.8 $5.66 Million - $6.54 Million
-88,592 Reduced 47.56%
97,668 $6.82 Million
Q3 2020

Nov 13, 2020
BUY
$63.69 - $70.22 $6.54 Million - $7.21 Million
102,692 Added 122.88%
186,260 $12.9 Million
Q2 2020

Aug 17, 2020
BUY
$58.54 - $67.94 $4.89 Million - $5.68 Million
83,568 New
83,568 $5.47 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Exencial Wealth Advisors, LLC Portfolio

Follow Exencial Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email